Global Cancer Gene Therapy Market reached US$ 4.7 billion in 2024 and is expected to reach US$ 13.2 billion by 2031 growing at a CAGR of 20% during the forecast period 2024-2031.

The Cancer Gene Therapy Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/cancer-gene-therapy-market?oppratik 

Cancer Gene Therapy Market Landscape Analysis :

Cancer gene therapy involves the modification or manipulation of genes within cancer cells or the patient's body to treat or prevent cancer, using techniques such as gene editing, viral vectors, or immune modulation. This market is expanding rapidly due to advancements in genomics, personalized medicine, and the growing pipeline of clinical trials targeting various cancer types.

Cancer Gene Therapy Market Dynamics:

The increasing global cancer burden is driving demand for advanced therapies like gene therapy, especially for conditions like non-small cell lung and breast cancer. As cancer cases rise, so do R&D efforts and interest in personalized medicine. According to the American Cancer Society (2024), lung cancer is the second most common cancer in the U.S., while WHO (2022) reports 2.3 million breast cancer cases globally. This expanding patient base fuels market growth opportunities.

Cancer Gene Therapy Market: Recent Industry Developments

✅May 2025 EMA's CHMP gave a positive opinion for conditional EU approval .

April 2025 - FDA awarded Breakthrough Therapy designation for BCB 276, a CAR T therapy targeting B7 H3, aimed at treating diffuse intrinsic pontine glioma (DIPG)

Strategic Players Driving the Cancer Gene Therapy Market Forward:

Novartis AG, Gilead Sciences, Inc., Editas Medicine, Transgene SA, Amgen Inc., Sorrento Therapeutics, Inc., BioNTech SE., Cellectis, ALLOGENE THERAPEUTICS, Cabaletta Bio, Inc. among others.

Research Methodology:

The global Cancer Gene Therapy Market research report employs a comprehensive dual-source approach, integrating both primary and secondary data collection methods to ensure robust market analysis. Our research framework systematically evaluates multiple industry-influencing variables, including regulatory frameworks and government policies, prevailing market conditions, competitive intensity levels, historical performance data, current market positioning, technological innovations and disruptions, emerging industry developments, cross-sector business impacts, market volatility patterns, growth prospects, potential market barriers, and strategic challenges facing industry participants.

Segment Covered in the Cancer Gene Therapy Market:

➠By Technique: In vivo Gene Therapy, Ex vivo Gene Therapy

➠By Therapy: Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, Others

➠By Application: Brain Cancer, Lung Cancer, Breast Cancer, Pancreatic Cancer, Liver Cancer, Others

➠By End-User: Hospitals, Cancer Centers, Others

Regional Analysis for Cancer Gene Therapy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Most Frequently Asked Questions in the Cancer Gene Therapy Market Research Industry:

➠ Who leads the Cancer Gene Therapy industry and what's their competitive positioning regarding capacity, performance, and profitability?

➠ What growth opportunities and market challenges do Cancer Gene Therapy market vendors face?

➠ Which segments show the highest growth potential and market share distribution?

➠ What factors are driving or limiting Cancer Gene Therapy market growth?

➠ What are the dominant sales and distribution strategies in the Cancer Gene Therapy industry?

Unlock 360° Market Intelligence with DataM Subscription Services:

https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape

✅ Technology Roadmap Analysis

✅ Sustainability Impact Analysis

✅ KOL / Stakeholder Insights

✅ Consumer Behavior & Demand Analysis

✅ Import-Export Data Monitoring

✅ Live Market & Pricing Trends

Contact Us -

Company Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.